Location, location, location. Does cannula site affect AID performance?
Rotate your injection or infusion sites. That’s a key message that anyone living with type 1 is delivered very early in their life with the […]
Automated Insulin Delivery
Commercial AID or Open Source? Some things to consider…
This is a classic question that comes up frequently within groups that are largely populated by members of the ¥WeAreNotWaiting community. It’s often included with […]
Glastonbury 2023: Rick Astley and The Blossoms play the Smiths…
Which seems like a suitable metaphor for a field test of an experimental algorithm that doesn’t require mealtime bolusing and uses stepcount to mediate how […]
Everybody’s moving – integrating stepcounts into Open Source Automated Insulin Delivery
Using activity data to change behaviour in AID systems.
Glucagon me… n=1 experiments with microbolusing glucagon part 2: quantifying use
Are two hormones and an algorithm enough? Or is diabetes far more complex than that?
Tidepool Loop. Approved but not yet available
With the recent news that Tidepool’s Loop has been approved by the FDA, the detail, that there are no pumps available that work with it, […]
Keep on movin’…. Factoring variation in activity into open source AID systems
With the past 18 months or working on Boost and using it, various patterns have shown their heads. In the past I’ve written about the […]
Technology for Diabetes that you can’t get yet: 3. Luna
Would sir like something to help you sleep? A forthcoming technology in the Diabetes world supposed to do just that.
Physical implementation of AID systems? What’s best?
Choosing an AID system presents lots of choices. The physical set up may make or break use of one for an end user.
More commercial AID systems. What do the trials tell us?
As many will be aware, at ADA Scientific Sessions this week, Medtronic announced the the outcomes of a number of trials of the 780G, including […]